Dashboard
Manage Tickers

DNA Ginkgo Bioworks Holdings, Inc.

NYSE ginkgobioworks.com


$ 12.40 $ 0.00 (0 %)    

Tuesday, 04-Nov-2025 04:30:48 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 621.70 $ 0.00 (0 %)
DIA $ 468.70 $ 0.00 (0 %)
SPY $ 674.28 $ 0.00 (0 %)
TLT $ 90.02 $ 0.00 (0 %)
GLD $ 366.96 $ 0.00 (0 %)
$ 12.79
$ 12.90
$ 12.32 x 57
$ 12.46 x 70
-- - --
$ 5.00 - $ 17.58
1,239,797
na
757.16M
$ 2.60
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 02-25-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-29-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-13-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-28-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-24-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ginkgo-bioworks-awarded-up-to-222m-contract-from-biopharmaceutical-manufacturing-preparedness-consortium-to-develop-innovations-to-lower-costs-of-local-biomanufacturing-of-monoclonal-antibodies
Ginkgo Bioworks Awarded Up To $22.2M Contr...
11/03/2025 13:13:40

Ginkgo Bioworks (NYSE: DNA) announced today that it has been awarded a contract through the Biomedical Advanced Research and De...

ginkgo-bioworks-extends-its-multi-year-partnership-with-bayer-to-continue-developing-biological-products-for-agriculture-focusing-on-microbial-nitrogen-fixation
Ginkgo Bioworks Extends Its Multi-Year Par...
10/31/2025 12:03:37

Ginkgo Bioworks (NYSE:DNA) today announced that the company has extended its multi-year strategic partnership with Bayer to adv...

ginkgo-bioworks-collaborates-with-strmbio-and-university-of-british-columbia-to-develop-in-vivo-chimeric-antigen-receptor-therapies-for-autoimmune-diseases
Ginkgo Bioworks Collaborates With STRM.BIO...
10/23/2025 12:20:04

Ginkgo Bioworks to apply its RNA construct design expertise to develop long-lived, tissue-specific, and highly potent in vivo C...

dell-select-medical-century-aluminum-and-other-big-stocks-moving-higher-on-wednesday
Dell, Select Medical, Century Aluminum And...
10/08/2025 14:39:06

btig-maintains-sell-on-ginkgo-bioworks-holdings-raises-price-target-to-9
BTIG Maintains Sell on Ginkgo Bioworks Hol...
08/25/2025 12:23:26

BTIG analyst Mark Massaro maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and raises the price target from $6 to $9.

5-healthcare-stocks-on-fire-this-week
5 Healthcare Stocks On Fire This Week
08/21/2025 12:24:39

Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech &...

ginkgo-bioworks-announces-strategic-partnership-to-scale-ai-drug-discovery-via-datapoints-platform
Ginkgo Bioworks Announces Strategic Partne...
08/20/2025 12:06:29

Ginkgo Bioworks (NYSE:DNA), which is building the leading platform for cell programming and biosecurity, today announced that i...

ginkgo-bioworks-files-for-mixed-shelf-up-to-500m
Ginkgo Bioworks Files For Mixed Shelf Up T...
08/07/2025 21:21:10

ginkgo-bioworks-holdings-q2-eps-110-beats-156-estimate-sales-5000m-beat-4161m-estimate
Ginkgo Bioworks Holdings Q2 EPS $(1.10) Be...
08/07/2025 21:11:17

Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(1.10) per share which beat the analyst consensus estimate of...

ginkgo-bioworks-holdings-affirms-fy2025-sales-guidance-of-167000m-187000m-vs-178213m-est
Ginkgo Bioworks Holdings Affirms FY2025 Sa...
08/07/2025 21:07:31

Ginkgo Bioworks Holdings (NYSE:DNA) affirms FY2025 sales outlook from $167.000 million-$187.000 million to $167.000 million-$18...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

ginkgo-bioworks-to-build-automated-anaerobic-phenotyping-platform-for-emsl-using-reconfigurable-automation-cart-technology
Ginkgo Bioworks To Build Automated Anaerob...
07/30/2025 13:04:35

Ginkgo will build a platform driven by its Reconfigurable Automation Carts (RACs) technology to enable EMSL's open-ended ex...

hewlett-packard-enterprise-magnite-gms-and-other-big-stocks-moving-higher-on-monday
Hewlett Packard Enterprise, Magnite, GMS A...
06/30/2025 15:29:29

ginkgo-bioworks-appoints-steven-coen-as-cfo
Ginkgo Bioworks Appoints Steven Coen As CFO
05/21/2025 20:07:40

Core News & Articles
Twist Bioscience And Ginkgo Bioworks Annou...
05/08/2025 12:13:53

New terms provide Twist with key license to long DNA technology and assetsGinkgo to continue ordering from Twist with no purcha...

ginkgo-bioworks-holdings-updates-fy2025-sales-guidance-from-16000m-18000m-to-16700m-18700m-vs-20201m-est
Ginkgo Bioworks Holdings Updates FY2025 Sa...
05/06/2025 21:04:12

Ginkgo previously issued 2025 guidance for Total revenue of $160-$180 million, Cell Engineering revenue of $110-$130 million; a...

ginkgo-bioworks-holdings-q1-eps-168-beats-169-estimate-sales-48m-beat-4312m-estimate
Ginkgo Bioworks Holdings Q1 EPS $(1.68) Be...
05/06/2025 21:03:38

Core News & Articles
Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

nvidia-backed-recursion-ginkgo-bioworks-rally-following-fdas-decision-to-end-animal-testing
Nvidia-Backed Recursion, Ginkgo Bioworks R...
04/14/2025 09:14:11

FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.

fastenal-posts-better-than-expected-sales-joins-simulations-plus-certara-and-other-big-stocks-moving-higher-on-friday
Fastenal Posts Better-Than-Expected Sales,...
04/11/2025 14:28:47

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION